BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 910385)

  • 21. Adsorption of Protein-Bound Uremic Toxins Through Direct Hemoperfusion With Hexadecyl-Immobilized Cellulose Beads in Patients Undergoing Hemodialysis.
    Yamamoto S; Sato M; Sato Y; Wakamatsu T; Takahashi Y; Iguchi A; Omori K; Suzuki Y; Ei I; Kaneko Y; Goto S; Kazama JJ; Gejyo F; Narita I
    Artif Organs; 2018 Jan; 42(1):88-93. PubMed ID: 28703401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined hemodialysis-hemoperfusion treatment reduces the time of substitutive therapy in chronic uremia.
    Stefoni S; Feliciangeli G; Coli L; Scolari MP; Bonomini V
    Int J Artif Organs; 1981 Jul; 4(4):186-91. PubMed ID: 7327760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Active carbon and its controversial ability to adsorb uremic toxins.
    Giordano C; Esposito R; Cirillo D; Betuel H; Fredel A; Pluvio M; Mazzola G; Longhi R; Manzo M
    Int J Artif Organs; 1984 Jul; 7(4):177-80. PubMed ID: 6490189
    [No Abstract]   [Full Text] [Related]  

  • 24. Short-term evaluation of charcoal hemoperfusion combined with dialysis in uremic patients.
    Winchester JF; Apiliga MT; Kennedy AC
    Kidney Int Suppl; 1976 Dec; (7):S315-9. PubMed ID: 1070554
    [No Abstract]   [Full Text] [Related]  

  • 25. Utilization of adsorbing materials for uremic blood purification.
    Denti E
    Biomater Med Devices Artif Organs; 1974; 2(3):295-300. PubMed ID: 4458819
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of uncoated activated carbon hemoperfusion in acute poisoning: in vitro studies.
    Tessore V; Luboz MP; Denti E
    Contrib Nephrol; 1982; 29():65-75. PubMed ID: 7075217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative studies on the effect of hemoperfusion and hemodialysis on the elimination of some uremic toxins.
    Trznadel K; Walasek L; Kidawa Z; Lutz W
    Clin Nephrol; 1978 Dec; 10(6):229-31. PubMed ID: 729215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis.
    Fagugli RM; De Smet R; Buoncristiani U; Lameire N; Vanholder R
    Am J Kidney Dis; 2002 Aug; 40(2):339-47. PubMed ID: 12148107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding the uremic syndrome through hemodialysis.
    Funck-Brentano JL
    Biomater Med Devices Artif Organs; 1974; 2(4):321-43. PubMed ID: 4462862
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical evaluation of the disc cone dialyzer.
    Steinmuller S; Horn E; Hamilton R; Bluemle LW; Henderson L
    Trans Am Soc Artif Intern Organs; 1971; 17():273-8. PubMed ID: 5158104
    [No Abstract]   [Full Text] [Related]  

  • 31. Changes in insulin binding during hemodialysis in uremic patients.
    Milutinović S; Breyer D; Molnar V; Stefović A; Janković N; Skrabalo Z; Rocić B
    Nephron; 1985; 41(4):307-13. PubMed ID: 3906417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitrogen balance and plasma amino acid levels in uremic patients fed an essential amino acid diet.
    Kopple JD; Swendseid ME
    Am J Clin Nutr; 1974 Aug; 27(8):806-12. PubMed ID: 4846405
    [No Abstract]   [Full Text] [Related]  

  • 33. Peak 7c and creatinine weekly clearances in various dialytic procedures.
    Icardi A; Carozzi S; Trasforini D; Moriero E; Lamperi S
    Life Support Syst; 1983; 1 Suppl 1():162-5. PubMed ID: 6336401
    [No Abstract]   [Full Text] [Related]  

  • 34. Middle molecule accumulation in uremia: an "extra uremic factor".
    Oulès R; Emond C; Claret G; Branger B; Mion H; Mion C
    Artif Organs; 1981; 4 Suppl():177-83. PubMed ID: 7295089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth and free amino acids in uremic hyperphagic rats.
    Kleinknecht C; Gros F; Jean G; Broyer M
    Am J Clin Nutr; 1980 Jul; 33(7):1690-5. PubMed ID: 7395790
    [No Abstract]   [Full Text] [Related]  

  • 36. The search for the uremic toxin: the case for carbamoylation of amino acids and proteins.
    Kraus LM; Kraus AP
    Wien Klin Wochenschr; 1998 Aug; 110(15):521-30. PubMed ID: 9782570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The use of haemocol hemoperfusion].
    Pall H
    Wien Klin Wochenschr Suppl; 1978; 89():1-12. PubMed ID: 351974
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparative study of dialysis techniques.
    Trafford JA; Free L; Sharpstone P; Evans R
    Nephron; 1984; 36(3):194-6. PubMed ID: 6700811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of renal substitutive programs on amino acid patterns in chronic uremia.
    Scolari MP; Stefoni S; Mosconi G; Colì L; Feliciangeli G; Baldrati L; Buscaroli A; Prandini R; Bonomini V
    Kidney Int Suppl; 1983 Dec; 16():S77-80. PubMed ID: 6376922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodialysis and plasma amino acid composition in chronic renal failure.
    Gulyassy PF; Peters JH; Lin SC; Ryan PM
    Am J Clin Nutr; 1968 Jun; 21(6):565-73. PubMed ID: 5666633
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.